PHARNEXT
LIVE

Serial Number

79137568

Owner

PHARNEXT

Attorney

Jeffrey A. Smith

Filing Date

Jun 20, 2013

Add to watchlist:

No watchlists yet
View on USPTO

PHARNEXT Trademark

Serial Number: 79137568 • Registration: 4611799

PHARNEXT is a trademark filed by PHARNEXT on June 20, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PHARNEXT (19 trademarks)

46 rue Saint Lazare

Entity Type: 99

Trademark Details

Filing Date

June 20, 2013

Registration Date

September 30, 2014

Published for Opposition

July 15, 2014

Cancellation Date

June 21, 2023

Goods & Services

Training services in the field of medicine; publishing of books and texts * in field of medicine *, namely, press articles, magazines, brochures; electronic publishing services, namely, publication of texts works of others on-line in the field of medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions and seminars in the field of medicine for non-business and non-commercial purposes; * teaching in the field of medicine *

Biological preparations for medical purposes for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; pharmaceutical preparations for human use for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; diagnostic preparations for medical diagnosis purposes; chemicals preparations for medical purposes, namely, for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; food supplements and nutritional supplements; dietetic food supplements for medical use; homeopathic and plant therapy compositions, namely, homeopathic supplements; sanitary preparations for medical use; pharmaceuticals preparations for skin care, hair care and hygiene; medical preparations for slimming; therapeutic medicated bath preparations; bath salts for medical use; dietary supplement beverages, namely, dietary supplemental drinks in the nature of vitamin and mineral beverages; appetite suppressants for medical use; barks for pharmaceutical use, namely, angostura bark for medical purposes, condurango bark for medical purposes, Croton bark for medical purposes and Croton bark for use as an anti-inflammatory; royal jelly for medical purposes; medicinal oils for medical use; chemical reagents for medical use, namely, biomarkers

Database management and collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics * in the field of medicine *; collection and systematization of information into computer databases * in the field of medicine *; public relations* in the field of medicine * ; communication, namely, promoting public awareness regarding disease treatments

Medical services; pharmaceutical advice

Pharmaceutical research and development; scientific research in the field of medicine; conducting of clinical trials and studies; chemical and biological analysis; laboratory research in the field of cosmetics, chemistry, bacteriology, biology, biotechnology and nutrition; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemicals, biological agents and pharmaceuticals; design and development of software * in the field of medicine *; scientific laboratory services; provision of information in the field of pharmaceuticals research, medical research and scientific research in the field of pharmaceuticals and clinical trials; chemical research on chemical reagents for medical use, namely, biomarkers

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 6, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 6, 2024 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 17, 2023 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 9, 2022 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 4, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 22, 2022 INTS
INVALIDATION PROCESSED
Apr 22, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 16, 2021 INTR
CANCELLED SECTION 71
Apr 16, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 30, 2019 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 6, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 7, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 8, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 26, 2017 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
May 23, 2016 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 15, 2016 INPR
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 15, 2015 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 15, 2015 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Jun 30, 2015 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 29, 2015 APRE
LIMITATION OF GOODS RECEIVED FROM IB
May 15, 2015 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 31, 2014 FICS
FINAL DISPOSITION PROCESSED
Dec 31, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 30, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2014 R.PR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 15, 2014 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 11, 2014 CRCV
NOTIFICATION PROCESSED BY IB
Jul 22, 2014 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 2, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 2, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 10, 2014 PREV
ASSIGNED TO LIE
Jun 5, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
May 22, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
May 22, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2014 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2014 REAP
REFUSAL PROCESSED BY IB
Nov 23, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 7, 2013 RFCS
REFUSAL PROCESSED BY MPU
Nov 7, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2013 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 1, 2013 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 25, 2013 REPR